BSEInsider Trading / SAST9h ago · 25 Sept 2026, 09:45 am
Pls find enclosed herewith closure of trading window intimation
Ajanta Pharma Ltd · 532331
✦ AI Summary
Ajanta Pharma Ltd has announced the closure of its trading window for dealing in securities from October 1, 2026, until 48 hours after the declaration of its second-quarter and half-year financial results for the period ended September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajanta Pharma Ltd - 532331 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
4acf7af1-c585-41c6-9497-d902885daea6.pdf
View document text
Ajanta Pharma Limited
Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000
Road, Chakala, Andheri (E), E legal.info@ajantapharma.com
Mumbai 400 093, India W www.ajantapharma.com
25th September 2026
BSE Limited National Stock Exchange of India
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/l,
Dalal Street, G block, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (East), Mumbai - 400 051
Scrip Code: BSE - AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ
Re: Closure of Trading Window
Dear Sir/Madam,
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended
from time to time and “Ajanta’s Code of Conduct for Insiders”, the Trading Window for
dealing in securities of the Company shall remain closed from Thursday, 1st October 2026 till
48 hours after the declaration of Financial Results of the Company for the second quarter and
half year ended 30th September 2026.
Kindly take the above information on record.
Thanking you,
Yours faithfully,
Gaurang Shah
Sr. VP- Legal & Company Secretary
Corporate Identity Number - L24230MH1979PLC022059